284 related articles for article (PubMed ID: 12669028)
21. Vaccine presentations and delivery technologies--what does the future hold?
Clements CJ; Wesselingh SL
Expert Rev Vaccines; 2005 Jun; 4(3):281-7. PubMed ID: 16026244
[TBL] [Abstract][Full Text] [Related]
22. Intraoral delivery of antimicrobials.
Raj PA; Dentino AR
Drug News Perspect; 2005; 18(6):362-74. PubMed ID: 16247514
[TBL] [Abstract][Full Text] [Related]
23. Vaccine manufacturing: challenges and solutions.
Ulmer JB; Valley U; Rappuoli R
Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
[TBL] [Abstract][Full Text] [Related]
24. Biopharmaceuticals: recent approvals and likely directions.
Walsh G
Trends Biotechnol; 2005 Nov; 23(11):553-8. PubMed ID: 16051388
[TBL] [Abstract][Full Text] [Related]
25. Oral heparin (Emisphere).
Dunn A
IDrugs; 2000 Jul; 3(7):817-24. PubMed ID: 16080057
[TBL] [Abstract][Full Text] [Related]
26. Orotransmucosal drug delivery systems: a review.
Madhav NV; Shakya AK; Shakya P; Singh K
J Control Release; 2009 Nov; 140(1):2-11. PubMed ID: 19665039
[TBL] [Abstract][Full Text] [Related]
27. The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins.
Motlekar NA; Youan BB
J Control Release; 2006 Jun; 113(2):91-101. PubMed ID: 16777255
[TBL] [Abstract][Full Text] [Related]
28. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
29. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
30. Drug delivery systems - an overview.
Jain KK
Methods Mol Biol; 2008; 437():1-50. PubMed ID: 18369961
[TBL] [Abstract][Full Text] [Related]
31. Advances in oral macromolecular drug delivery.
Hwang SR; Byun Y
Expert Opin Drug Deliv; 2014 Dec; 11(12):1955-67. PubMed ID: 25078141
[TBL] [Abstract][Full Text] [Related]
32. Microfabricated nanochannel implantable drug delivery devices: trends, limitations and possibilities.
Gardner P
Expert Opin Drug Deliv; 2006 Jul; 3(4):479-87. PubMed ID: 16822223
[TBL] [Abstract][Full Text] [Related]
33. The pharmaceutical biochemistry group: where pharmaceutical chemistry meets biology and drug delivery.
Kalia YN; Perozzo R; Scapozza L
Chimia (Aarau); 2012; 66(5):313-9. PubMed ID: 22867543
[TBL] [Abstract][Full Text] [Related]
34. The rise and rise of drug delivery.
Rosen H; Abribat T
Nat Rev Drug Discov; 2005 May; 4(5):381-5. PubMed ID: 15864267
[TBL] [Abstract][Full Text] [Related]
35. A timely reassessment of early prediction in the bioavailability of orally administered drugs.
Larsen T; Link A
Angew Chem Int Ed Engl; 2005 Jul; 44(29):4432-4. PubMed ID: 15984039
[No Abstract] [Full Text] [Related]
36. In vitro - in vivo correlation: from theory to applications.
Emami J
J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic oligonucleotides: the state-of-the-art in purification technologies.
Sanghvi YS; Schulte M
Curr Opin Drug Discov Devel; 2004 Nov; 7(6):765-76. PubMed ID: 15595437
[TBL] [Abstract][Full Text] [Related]
38. Advances in the delivery of treatments for Parkinson's disease.
Johnston TH; Fox SH; Brotchie JM
Expert Opin Drug Deliv; 2005 Nov; 2(6):1059-73. PubMed ID: 16296809
[TBL] [Abstract][Full Text] [Related]
39. Industrial perspective in ocular drug delivery.
Ali Y; Lehmussaari K
Adv Drug Deliv Rev; 2006 Nov; 58(11):1258-68. PubMed ID: 17079049
[TBL] [Abstract][Full Text] [Related]
40. An insight into gastrointestinal macromolecule delivery using physical oral devices.
Kaffash E; Shahbazi MA; Hatami H; Nokhodchi A
Drug Discov Today; 2022 Aug; 27(8):2309-2321. PubMed ID: 35460891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
